ID   IP4
AC   CVCL_B7IN
DR   Wikidata; Q112929869
RX   PubMed=34429452;
CC   Doubling time: 55 hours (PubMed=34429452).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro772_His773insProTyrAsnPro (P772_H773insPYNP); Zygosity=Heterozygous (PubMed=34429452).
CC   Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707.
ST   Source(s): PubMed=34429452
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D16S539: 12,14
ST   D18S51: 19,21
ST   D21S11: 30,31
ST   D3S1358: 16
ST   D6S1043: 13
ST   D8S1179: 10,15
ST   vWA: 14,17
DI   NCIt; C6871; Sinonasal inverted papilloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
RX   PubMed=34429452; DOI=10.1038/s41598-021-96444-y; PMCID=PMC8384845;
RA   Nukpook T., Ekalaksananan T., Kiyono T., Kasemsiri P.,
RA   Teeramatwanich W., Vatanasapt P., Chaiwiriyakul S.,
RA   Ungarreevittaya P., Kampan J., Muisuk K., Pientong C.;
RT   "Establishment and genetic characterization of cell lines derived from
RT   proliferating nasal polyps and sinonasal inverted papillomas.";
RL   Sci. Rep. 11:17100.1-17100.14(2021).
//